Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
topic
Journal for ImmunoTherapy of Cancer
Journal for ImmunoTherapy of Cancer
1178 Tumor-immune cell targeting chimeras (TICTACs): targeted immune reprogramming of the tumor microenvironment
Mariko
Morimoto
,
Nicholas A
Till
,
Carolyn R
Bertozzi
Journal for ImmunoTherapy of Cancer
Nov 2023,
11
(Suppl 1)
A1298;
DOI:
10.1136/jitc-2023-SITC2023.1178
905 Moving from awareness to adoption: live virtual training equips community physicians to select first-line immunotherapy for advanced NSCLC
Kadrin
Wilfong
,
Michael
Beyer
,
Heather
Drew
Journal for ImmunoTherapy of Cancer
Nov 2023,
11
(Suppl 1)
A1007;
DOI:
10.1136/jitc-2023-SITC2023.0905
906 Leveraging CME to address social determinants of health in immunotherapy selection for advanced NSCLC: empowering clinicians for equitable care
Kadrin
Wilfong
,
Michael
Beyer
,
Heather
Drew
Journal for ImmunoTherapy of Cancer
Nov 2023,
11
(Suppl 1)
A1008;
DOI:
10.1136/jitc-2023-SITC2023.0906
907 Enhancing multidisciplinary collaboration for effective integration of perioperative immunotherapies in stage I-III resectable NSCLC: a continuing medical education (CME) approach
Kadrin
Wilfong
,
Michael
Beyer
,
Heather
Drew
Journal for ImmunoTherapy of Cancer
Nov 2023,
11
(Suppl 1)
A1009;
DOI:
10.1136/jitc-2023-SITC2023.0907
908 The impact of a full-time live harp musician on the oncology floors in improving the patient’s and caregiver’s well-being
Fnu
Anamika
,
Akshit
Chitkara
,
Rushin
Patel
Journal for ImmunoTherapy of Cancer
Nov 2023,
11
(Suppl 1)
A1010;
DOI:
10.1136/jitc-2023-SITC2023.0908
909 Impact of one-on-one video education in increasing turnover for colorectal carcinoma screening – a systemic review
Akshit
Chitkara
,
Femina
Patel
,
Fnu
Anamika
,
Rushin
Patel
,
Ujjwal
Soni
,
Nandini
Gowda
Journal for ImmunoTherapy of Cancer
Nov 2023,
11
(Suppl 1)
A1011;
DOI:
10.1136/jitc-2023-SITC2023.0909
910 Development and user testing of a website with information for cancer patients who have pre-existing autoimmune disease and are considering immune checkpoint inhibitors (ICIs)
Maria A
Lopez-Olivo
,
Maria E
Suarez-Almazor
,
Gabrielle F
Duhon
,
McKenna
Erck
,
Cassandra
Calabrese
,
Mehmet
Altan
,
Hussain
Tawbi
,
Alexa
Meara
,
Clifton
Bingham
,
Adi
Diab
,
Viola B
Leal
,
Robert J
Volk
Journal for ImmunoTherapy of Cancer
Nov 2023,
11
(Suppl 1)
A1012;
DOI:
10.1136/jitc-2023-SITC2023.0910
911 Improved lifelines needed for all lines: real-world treatment patterns and attrition rates in US patients with non-driver mutation metastatic non-small cell lung cancer
Adam
Schoenfeld
,
Chen
Hu
,
Ravi
Rajaram
,
Josephine
Feliciano
,
Urmila
Chandran
,
Charlene
Wong
,
U
Hariharan
,
Iftekhar
Kalsekar
,
Tianyi
Wang
,
Qing
Huang
,
Aisha
Hasan
Journal for ImmunoTherapy of Cancer
Nov 2023,
11
(Suppl 1)
A1013-A1014;
DOI:
10.1136/jitc-2023-SITC2023.0911
912 A comparison of 37+ immune populations in whole blood by CyTOF® flow cytometry collected with 4 different preservation reagents
Geneve
Awong
,
Deeqa
Mahamed
,
Vinicius
Motta
,
Stephen
Li
,
Kevin
Brown
,
Thirumahal
Selvanantham
Journal for ImmunoTherapy of Cancer
Nov 2023,
11
(Suppl 1)
A1015;
DOI:
10.1136/jitc-2023-SITC2023.0912
913 Tumor immune micro-environment (TIME) Atlas for prostate cancer bone metastasis
Kenneth
Canubas
,
Michael
Xu
,
William
Kelly
,
Jennifer
Marte
,
Houssein Abdul
Sater
,
James L
Gulley
,
Wiem
Lassoued
Journal for ImmunoTherapy of Cancer
Nov 2023,
11
(Suppl 1)
A1016;
DOI:
10.1136/jitc-2023-SITC2023.0913
Pages
« first
‹ previous
…
122
123
124
125
126
127
128
129
130
…
next ›
last »
Special collections
COVID-19
(45)
Editor's choice
JITC
Aging and diversity, equity, and inclusion (DEI) with regard to cancer immunotherapy and understudied populations
Aging and diversity, equity, and inclusion (DEI) with regard to cancer immunotherapy and understudied populations
Basic Tumor Immunology
(560)
Case Reports
(191)
Clinical Trials Monitor
(17)
Clinical/Translational Cancer Immunotherapy
(983)
Commentary/Editorials
(153)
Computational I-O
(4)
COVID-19 and Cancer Immunotherapy
(10)
Emerging Immunotherapeutic Agents
(5)
Guidelines and Consensus Statements
(56)
Guidelines and Consensus Statements
(53)
Imaging and Immunotherapy
(9)
Immune Cell Therapies and Immune Cell Engineering
(242)
Immune Checkpoints - Beyond PD-1
(8)
Immune Checkpoints Beyond PD-1 Series
(8)
Immune Monitoring Technology Primers
(12)
Immunotherapy Biomarkers
(437)
Liquid Biopsies
(10)
Microbial-Based Cancer Immunotherapy
(4)
Oncolytic and Local Immunotherapy
(151)
Reviews
(245)
The Next Wave of Immuno-oncology: A Roadmap from the Society for Immunotherapy of Cancer (SITC)
(1)
Open access
(5026)
Press releases
(2)
